title: Factors that influence use of a home cardiorespiratory monitor for infants: the collaborative home infant monitoring evaluation.
abstract: BACKGROUND
  As part of the Collaborative Home Infant Monitoring Evaluation, a home monitor was developed to record breathing, heart rate, other physiologic variables, and the time the monitor was used.
  
  
  OBJECTIVE
  To determine the frequency of monitor use, factors that influence use, and validity of a model developed to predict use.
  
  
  METHODS
  We developed a model to predict monitor use using multiple linear regression analysis; we then tested the validity of this model to predict adherence for the first week of monitoring and for the subsequent 4-week period (weeks 2-5).
  
  
  METHODS
  Clinical research centers in Chicago, Ill; Cleveland, Ohio; Honolulu, Hawaii; Los Angeles, Calif; and Toledo, Ohio. Patients Preterm infants, infants younger than 1 month with a history of autopsy-confirmed sudden infant death syndrome in a sibling, and infants with an idiopathic apparent life-threatening event were divided into 2 cohorts based on enrollment date. Main Outcome Measure Mean hours of monitor use per week.
  
  
  RESULTS
  In cohort 1, the variables available before monitoring were only weakly associated with total hours of monitor use in weeks 2 to 5 (total model r(2) = 0.08). However, when hours of monitor use in week 1 were included as a variable to predict monitor use in weeks 2 to 5, the r(2) increased to 0.64 for hours of monitor use per week.
  
  
  CONCLUSIONS
  Our data show that monitor use in the first week was the most important variable for predicting subsequent monitor use. The study suggests that a major focus of home monitoring should be adherence in the first week, although it remains to be tested whether this adherence can be altered.
authors.affiliation: Department of Pediatrics, Rush Medical College of Rush University, Rush Children's Hospital, Chicago, IL, USA.
authors.forename: Jean M
authors.initials: JM
authors.lastname: Silvestri
authors.forename: George
authors.initials: G
authors.lastname: Lister
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Corwin
authors.forename: Sheilah M
authors.initials: SM
authors.lastname: Smok-Pearsall
authors.forename: Terry M
authors.initials: TM
authors.lastname: Baird
authors.forename: David H
authors.initials: DH
authors.lastname: Crowell
authors.forename: Jean
authors.initials: J
authors.lastname: Cantey-Kiser
authors.forename: Carl E
authors.initials: CE
authors.lastname: Hunt
authors.forename: Larry
authors.initials: L
authors.lastname: Tinsley
authors.forename: Paula H
authors.initials: PH
authors.lastname: Palmer
authors.forename: Rebecca S
authors.initials: RS
authors.lastname: Mendenhall
authors.forename: Toke T
authors.initials: TT
authors.lastname: Hoppenbrouwers
authors.forename: Michael R
authors.initials: MR
authors.lastname: Neuman
authors.forename: Debra E
authors.initials: DE
authors.lastname: Weese-Mayer
authors.forename: Marian
authors.initials: M
authors.lastname: Willinger
mesh_terms: D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D005260:Female; D006701:Home Nursing; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016014:Linear Models; D008297:Male; D017533:Marital Status; D008991:Monitoring, Physiologic / Q000295:instrumentation*; D010290:Parents / Q000523:psychology; D010349:Patient Compliance; D017286:Polysomnography; D015203:Reproducibility of Results; D019141:Respiratory System Agents / Q000627:therapeutic use; D012891:Sleep Apnea Syndromes / Q000175:diagnosis*; D013398:Sudden Infant Death / Q000517:prevention & control*; D014481:United States; D014970:Xanthines / Q000627:therapeutic use
chemical_list: D019141:Respiratory System Agents; D014970:Xanthines; C008514:methylxanthine